Uncategorized Archives - Page 32 of 221

WednesdayFeb 16, 2022 11:24 am

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (PDE5 inhibitor) sildenafil as potential use for erectile dysfunction management. A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream (https://cnw.fm/SOjPD). During the animal study, it…

MondayFeb 14, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infection Cannabis cultivator and brand builder Flora Growth Corp. has filed a provisional patent application for a cannabinoid-based formula that it is simultaneously seeking approval from Colombia’s food and drug regulatory authority for a study and potential clinical trial in…

FridayFeb 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Shows Promise in Improving Performance, Speed of ED Drugs

Health and wellness drug bio-effectiveness innovator Lexaria Bioscience is advancing human testing of its patented DehydraTECH(TM) technology for the potential treatment of high blood pressure and heart disease Lexaria also recently announced that DehydraTECH boosted the speed and effectiveness of sildenafil in laboratory rats for the potential treatment of erectile dysfunction (“ED”) The company’s statement notes that DehydraTECH-processed sildenafil “delivered 74% more sildenafil into the bloodstream on average than the concentration-matched, generic control formulation” ED affects some 30 million men in the United States and is expected to affect about 322 million men worldwide by 2025 Lexaria Bioscience (NASDAQ: LEXX),…

ThursdayFeb 10, 2022 9:30 am

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo presented by 3Chi arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives,…

WednesdayFeb 09, 2022 10:00 am

The New England Cannabis Convention To Be Held In Boston

Cannabis growers, traders, industry professionals, and enthusiasts are invited to attend the New England Cannabis Convention (“NECANN”), on March 18-20, 2022. NECANN events, organized since 2014 are considered as one of the largest cannabis events on the east coast. The NECANN events attract a huge number of Hemp, MMJ and Cannabis traders/professionals in the Northeast in the annual Boston Cannabis Convention. These events are the home base for the New England cannabis industry. The New England Cannabis Convention in Boston offers a viable avenue for learning the intricacies of the Cannabis Industry and establishing networking and communication among cannabis growers,…

TuesdayFeb 08, 2022 12:50 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotine The company has big plans for 2022, a year it expects to undertake three ground-breaking studies Lexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnerships The company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing fees and royalties For Lexaria Bioscience (NASDAQ: LEXX), a drug delivery company whose patented DehydraTECH(TM) technology has proven effective in improving bioavailability, speed of onset, and efficiency of orally-delivered fat-soluble active molecules…

MondayFeb 07, 2022 12:25 pm

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

Joël Reyes’ appointment marks the third appointment in the first month of the 2022 calendar year Mr. Reyes will be responsible for implementing operational excellence across the entire organization, starting with its Columbian activities His appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower Flora Growth (NASDAQ: FLGC) embarked on an aggressive hiring campaign to kick off the 2022 calendar year, starting with the appointment of Derek Pedro as an advisor to its Cosechemos cultivation facility (https://cnw.fm/HRIoW). This was then followed by…

FridayFeb 04, 2022 10:19 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

BevCanna Enterprises Inc is a diversified health & wellness beverage and natural products companies which deals in the manufacture and distribution of both, in-house brands, and white-label clients The company currently boasts over 3,000 points of distribution and online through which it retails the company’s market-leading TRACE brand, its Pure Therapy natural health products as well as its various, cannabis infused beverages. BevCanna’s strong execution recently saw it report 3Q2021 revenues of $1.1 million, representing a rise of over 1,000% relative to a year ago BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food…

ThursdayFeb 03, 2022 10:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

Cannabicitran is the first of four new rare cannabinoids InMed is planning to launch in the first half of the year to meet growing inbound demand The launch demonstrates InMed’s ability to produce rare cannabinoids at scale, something only very few companies have achieved BayMedica acquisition, other key achievements in 2021, are positioning the company as a leading supplier of rare cannabinoids in the health and wellness sector A leader in the research, development, manufacturing and commercialization of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM) has begun the new year from a more prominent position in the market, following key acquisitions…

WednesdayFeb 02, 2022 2:05 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clients Company deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North America Company actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified health and wellness beverage and natural products company developing and manufacturing a diverse portfolio of alkaline, plant-based, and cannabinoid beverages and supplements for in-house brands and white-label clients alike. Founded in 2017, BevCanna…

News and publishing service for hemp related companies

Contact us: 512.354.7000

Category: Uncategorized